This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignee: Innovent Biologics (Suzhou) Co., Ltd.. Active years: 2022-2025.
Company Filing History:
Years Active: 2022-2025
Title: Innovations of Xinzhen Shi in Biologics
Introduction
Xinzhen Shi is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of biologics, particularly in the development of novel therapeutic proteins. With a total of two patents to his name, his work focuses on advancing medical treatments through innovative approaches.
Latest Patents
Xinzhen Shi's latest patents include "Interleukin-2 and use thereof" and "Anti-TIGIT antibody and use thereof." The first patent relates to a novel interleukin-2 (IL-2) mutant protein that exhibits reduced IL-2Rα receptor binding ability and increased IL-2Rβ receptor binding ability compared to the wild-type IL-2. This invention also encompasses a fusion protein, an immunoconjugate, and methods for preparing the IL-2 mutant protein, along with its pharmaceutical applications. The second patent focuses on a novel antibody and its fragments that specifically bind to TIGIT, along with related nucleic acids and their therapeutic and diagnostic uses.
Career Highlights
Xinzhen Shi is currently associated with Innovent Biologics (Suzhou) Co., Ltd., where he continues to push the boundaries of biologic therapies. His work has been instrumental in developing innovative solutions that address critical health challenges.
Collaborations
Xinzhen Shi collaborates with notable colleagues, including Junjian Liu and Pan Zhang, who contribute to his research and development efforts.
Conclusion
Xinzhen Shi's innovative work in the field of biologics exemplifies the impact of scientific research on healthcare advancements. His patents reflect a commitment to improving therapeutic options for patients.